Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Veterinary Biologics Market – Global Industry Analysis and Opportunity Assessment, 2019-2029

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Key Success Factors

    4.1. Regulatory Scenario

5. Global Veterinary Biologics Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018and Forecast, 2019-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

    6.2. Forecast Factors – Relevance & Impact

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029

        7.3.1. Vaccines

            7.3.1.1. Attenuated Live Vaccines

            7.3.1.2. Conjugate Vaccines

            7.3.1.3. Inactivated Vaccines

            7.3.1.4. Subunit Vaccines

            7.3.1.5. Toxoid Vaccines

            7.3.1.6. DNA Vaccines

            7.3.1.7. Recombinant Vaccines

        7.3.2. Bacterial Extracts

        7.3.3. Monoclonal Antibody

        7.3.4. Immunomodulators

            7.3.4.1. Cytokines

            7.3.4.2. Others

        7.3.5. Allergenic Extracts

    7.4. Market Attractiveness Analysis By Product Type 

8. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, by Animal Type 

    8.1. Introduction / Key Findings

    8.2. Historical Veterinary Biologics Market Size (US$ Mn) Analysis By Animal Type, 2014 – 2018

    8.3. Current and Future Veterinary Biologics Market Size (US$ Mn) Analysis By Animal Type, 2019 – 2029

        8.3.1. Companion Animals

            8.3.1.1. Canine

            8.3.1.2. Avian

            8.3.1.3. Feline

        8.3.2. Livestock Animals

            8.3.2.1. Aquatic

            8.3.2.2. Bovine

            8.3.2.3. Porcine

            8.3.2.4. Ovine/Caprine

            8.3.2.5. Poultry

        8.3.3. Equine

    8.4. Market Attractiveness Analysis of Antitoxins Market By Animal Type

9. Global Veterinary Biologics – Cytokines Market Analysis 2014-2018 and Forecast 2019-2029, by Animal Type 

    9.1. Historical Cytokines Market Size (US$ Mn) Analysis By Animal Type, 2014 – 2018

    9.2. Current and Future Cytokines Market Size (US$ Mn) Analysis By Animal Type, 2019 – 2029

        9.2.1. Companion Animals

            9.2.1.1. Canine

            9.2.1.2. Avian

            9.2.1.3. Feline

        9.2.2. Livestock Animals

            9.2.2.1. Aquatic

            9.2.2.2. Bovine

            9.2.2.3. Porcine

            9.2.2.4. Ovine/Caprine

            9.2.2.5. Poultry

        9.2.3. Equine 

10. Global Veterinary Biologics – Other Immunomodulatory Biologics Market Analysis 2014-2018 and Forecast 2019-2029, by Animal Type 

    10.1. Historical Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal Type, 2014 – 2018

    10.2. Current and Future Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal Type, 2019 – 2029

        10.2.1. Companion Animals

            10.2.1.1. Canine

            10.2.1.2. Avian

            10.2.1.3. Feline

        10.2.2. Livestock Animals

            10.2.2.1. Aquatic

            10.2.2.2. Bovine

            10.2.2.3. Porcine

            10.2.2.4. Ovine/Caprine

            10.2.2.5. Poultry

        10.2.3. Equine 

11. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

    11.1.  Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 – 2018

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

        11.3.1. Veterinary Clinics

        11.3.2. Veterinary Hospitals

        11.3.3. Veterinary Research Institutes

        11.3.4. Retail Pharmacies

    11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Animal Type, 2014 – 2018

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. South Asia

        12.3.5. East Asia

        12.3.6. Oceania

        12.3.7. Middle East & Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product Type

        13.3.3. By Animal Type

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product Type

        13.4.3. By Animal Type

        13.4.4. By Distribution Channel

    13.5. Key Market Participants – Intensity Mapping

    13.6. Drivers and Restraints – Impact Analysis

14. Latin America Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Rest of Latin America

        14.3.2. By Product Type

        14.3.3. By Animal Type

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product Type

        14.4.3. By Animal Type

        14.4.4. By Distribution Channel

    14.5. Key Market Participants – Intensity Mapping

    14.6. Drivers and Restraints – Impact Analysis

15. Europe Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

    15.3. Market Size (US$ Mn) and By Market Taxonomy, 2019 – 2029

        15.3.1.  By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product Type

        15.3.3. By Animal Type

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product Type

        15.4.3. By Animal Type

        15.4.4. By Distribution Channel

    15.5. Key Market Participants – Intensity Mapping

    15.6. Drivers and Restraints – Impact Analysis

16. South Asia Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

    16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        16.3.1.  By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product Type

        16.3.3. By Animal Type

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product Type

        16.4.3. By Animal Type

        16.4.4. By Distribution Channel

    16.5. Key Market Participants – Intensity Mapping

    16.6. Drivers and Restraints – Impact Analysis

17. East Asia Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

    17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        17.3.1.  By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Product Type

        17.3.3. By Animal Type

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product Type

        17.4.3. By Animal Type

        17.4.4. By Distribution Channel

    17.5. Key Market Participants – Intensity Mapping

    17.6. Drivers and Restraints – Impact Analysis

18. Oceania Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

    18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product Type

        18.3.3. By Animal Type

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product Type

        18.4.3. By Animal Type

        18.4.4. By Distribution Channel

    18.5. Key Market Participants – Intensity Mapping

    18.6. Drivers and Restraints – Impact Analysis

19. MEA Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

    19.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

        19.4.1.  By Country

            19.4.1.1. GCC Countries

            19.4.1.2. Turkey

            19.4.1.3. Northern Africa

            19.4.1.4. South Africa

            19.4.1.5. Rest of MEA

        19.4.2. By Product Type

        19.4.3. By Animal Type

        19.4.4. By Distribution Channel

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product Type

        19.5.3. By Animal Type

        19.5.4. By Distribution Channel

    19.6. Key Market Participants – Intensity Mapping

    19.7. Drivers and Restraints – Impact Analysis

20. Emerging Countries Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. China Veterinary Biologics Market Analysis

        20.2.1. Introduction

        20.2.2. PEST Analysis

        20.2.3. Market Value Proportion Analysis by Market Taxonomy

        20.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.2.4.1. By Product Type

            20.2.4.2. By Animal Type

            20.2.4.3. By Distribution Channel

    20.3. India Veterinary Biologics Market Analysis

        20.3.1. Introduction

        20.3.2. PEST Analysis

        20.3.3. Market Value Proportion Analysis by Market Taxonomy

        20.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.3.4.1. By Product Type

            20.3.4.2. By Animal Type

            20.3.4.3. By Distribution Channel

    20.4. Brazil Veterinary Biologics Market Analysis

        20.4.1. Introduction

        20.4.2. PEST Analysis

        20.4.3. Market Value Proportion Analysis by Market Taxonomy

        20.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.4.4.1. By Product Type

            20.4.4.2. By Animal Type

            20.4.4.3. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. Product foot print by Players

        21.4.2. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

        22.3.1. Elanco Animal Health

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Product Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. Ceva

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Product Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. Phibro Animal Health Corporation 

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Product Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. Boehringer Ingelheim

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Product Strategy

                22.3.4.5.3. Channel Strategy

        22.3.5. Zoetis, Inc.

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Product Strategy

                22.3.5.5.3. Channel Strategy

        22.3.6. Merck Animal Health

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Product Strategy

                22.3.6.5.3. Channel Strategy

        22.3.7. Virbac

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Product Strategy

                22.3.7.5.3. Channel Strategy

        22.3.8. Hester Biosciences Limited

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Product Strategy

                22.3.8.5.3. Channel Strategy

        22.3.9. Colorado Serum Company

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Product Strategy

                22.3.9.5.3. Channel Strategy

        22.3.10. Addison Biological Laboratory, Inc.

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Product Strategy

                22.3.10.5.3. Channel Strategy

        22.3.11. American Animal Health, Inc.

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.11.4. Sales Footprint

            22.3.11.5. Strategy Overview

                22.3.11.5.1. Marketing Strategy

                22.3.11.5.2. Product Strategy

                22.3.11.5.3. Channel Strategy

        22.3.12. HIPRA

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.12.4. Sales Footprint

            22.3.12.5. Strategy Overview

                22.3.12.5.1. Marketing Strategy

                22.3.12.5.2. Product Strategy

                22.3.12.5.3. Channel Strategy

        22.3.13. Bimeda Inc. (Texas Vet Lab, Inc.)

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.13.4. Sales Footprint

            22.3.13.5. Strategy Overview

                22.3.13.5.1. Marketing Strategy

                22.3.13.5.2. Product Strategy

                22.3.13.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote